TNF inhibitors for treatment of bowel disease not linked with increased risk of cancer
In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer ...
Jun 17, 2014
1
0